May 29, 2019
MSD and Bayer Yakuhin rolled out their hypercholesterolemia drug Rosuzet (ezetimibe + rosuvastatin), a fixed-dose combo pairing Zetia (ezetimibe) and Crestor (rosuvastatin), in Japan on May 28. The product, which will be jointly marketed by the two companies, carries an...read more